Jing-sheng Zhang

Suggest Changes
Learn More
BACKGROUND AND OBJECTIVE The effect of gefitinib on advanced non-small cell lung cancer (NSCLC) was various. How to choose the sensitive patients and improve the effect was difficulty in clinic. This(More)
  • 1